⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL10894685 | 1.00 | — | — | |
| Ethane SCHEMBL28257892 | 1.00 | — | — | |
| Ethane SCHEMBL10823097 | 1.00 | — | — | |
| Ethane SCHEMBL7314788 | 0.87 | — | — | |
| Ethane SCHEMBL9837785 | 0.87 | — | — | |
| Ethane SCHEMBL45 | 0.82 | — | — | |
| Ethane SCHEMBL11665218 | 0.82 | — | — | |
| Ethane SCHEMBL119366 | 0.82 | — | — | |
| Ethane SCHEMBL11324909 | 0.82 | — | — | |
| Ethane SCHEMBL23673679 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 300 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118086985-A | Brightening agent for acid copper electroplating of printed circuit board | 广东利尔化学有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-115350330-B | Application of electronegative micromolecule regulated surface in protein differential adhesion | 北京化工大学 | 2023-10-20 | — | — | CN | claimed |
| CN-116855318-A | Glass cleaning agent and preparation method and application thereof | 杭州老板电器股份有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-116724998-A | Efficient antioxidant donkey sperm diluent as well as preparation method and application thereof | 内蒙古自治区农牧业科学院 | 2023-09-12 | — | — | CN | claimed |
| CN-116724999-A | Diluent for promoting donkey sperm to supply energy and preparation method and application thereof | 内蒙古自治区农牧业科学院 | 2023-09-12 | — | — | CN | claimed |
| CN-116408051-A | Sulfonic acid anion hybridization porous material, preparation method and ethylene-ethane separation method | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-116369304-A | Cell freezing solution without animal source component and preparation method thereof | 翌圣生物科技(上海)股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-111426772-B | Method for determining related substances of chlortetracycline hydrochloride by HPLC gradient elution method | 江西省药品检验检测研究院 | 2022-02-22 | — | — | CN | claimed |
| CN-106698626-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-106698620-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-106698619-A | Composition formula of water treatment flocculating agent | 威海英卡瑞环保科技有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-106698618-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-106379974-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-02-08 | — | — | CN | claimed |
| CN-106379973-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-02-08 | — | — | CN | claimed |
| CN-106379972-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-02-08 | — | — | CN | claimed |
| CN-105861124-A | Cold-rolled emulsified liquid with iron powder self-dispersing performance and preparation method thereof | 北京科技大学 | 2016-08-17 | — | — | CN | claimed |
| CN-104053646-A | Method for producing 3-mercaptopropionic acid, and carbonic acid ester composition having mercapto group using same, and method for producing thiourethane-based optical materials | KOC SOLUTION CO LTD | 2014-09-17 | — | — | CN | claimed |
| US-20040225153-A1 | Synthesis of polyphosphazenes with sulfonimide side groups | THE PENN STATE RESEARCH FOUNDATION | 2004-11-11 | — | — | US | claimed |
| WO-2004072141-A2 | SYNTHESIS OF POLYPHOSPHAZENES WITH SULFONIMIDE SIDE GROUPS | THE PENN STATE RESEARCH FOUNDATION (US) | 2004-08-26 | — | — | WO | claimed |
| EP-4384483-B1 | FUNCTIONALIZED PHOSPHONATES, AND WATER-SOLUBLE SALTS AND N-OXIDE DERIVATIVES THEREOF, AND METHOD OF USE THEREOF AS SCALE INHIBITOR | DORF KETAL BRASIL LTDA BRAZIL (BR) | 2025-05-07 | — | — | EP | disclosed |
| US-20240351930-A1 | FUNCTIONALIZED PHOSPHONATES, AND WATER-SOLUBLE SALTS AND N-OXIDE DERIVATIVES THEREOF, AND METHOD OF USE THEREOF AS SCALE INHIBITOR | DORF KETAL BRASIL LTDA, BRAZIL (BR) | 2024-10-24 | — | — | US | disclosed |
| US-20240208929-A1 | HYDROXYPYRIDINE HSD17B13 INHIBITORS AND USES THEREOF | INIPHARM, INC. | 2024-06-27 | — | — | US | disclosed |
| WO-2024126117-A1 | PYRIMIDINONE DERIVATIVES AS PESTICIDAL COMPOUNDS | BASF SE (DE) | 2024-06-20 | — | — | WO | disclosed |
| EP-4384483-A1 | FUNCTIONALIZED PHOSPHONATES, AND WATER-SOLUBLE SALTS AND N-OXIDE DERIVATIVES THEREOF, AND METHOD OF USE THEREOF AS SCALE INHIBITOR | DORF KETAL BRASIL LTDA, BRAZIL (BR) | 2024-06-19 | — | — | EP | disclosed |
| CN-118086985-A | Brightening agent for acid copper electroplating of printed circuit board | 广东利尔化学有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-11964971-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| WO-2024056782-A1 | SULFONE-SUBSTITUTED PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024054840-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | SIONNA THERAPEUTICS (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-4320111-A1 | HYDROXYPYRIDINE HSD17B13 INHIBITORS AND USES THEREOF | Inipharm, Inc. (US) | 2024-02-14 | — | — | EP | disclosed |
| US-20240043431-A1 | Sulfoximine Pesticides | BASF SE (DE) | 2024-02-08 | — | — | US | disclosed |
| WO-2024022286-A1 | MACROCYCLIC EGFR INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | 上海和誉生物医药科技有限公司 | 2024-02-01 | — | — | WO | disclosed |
| EP-4311577-A2 | METALLOENZYME INHIBITOR COMPOUNDS | Ji Xing Pharmaceuticals Hong Kong Limited (HK) | 2024-01-31 | — | — | EP | disclosed |
| EP-4065575-B1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LTD (IN) | 2024-01-31 | — | — | EP | disclosed |
| CN-117051455-B | Tinning and photoresist removing process method for IC lead frame | 宁波德洲精密电子有限公司 | 2024-01-09 | — | — | CN | disclosed |
| WO-2024006781-A1 | ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF | RELAY THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| US-11845744-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| EP-3562487-B1 | METALLOENZYME INHIBITOR COMPOUNDS | JI XING PHARMACEUTICALS HONG KONG LTD (HK) | 2023-11-29 | — | — | EP | disclosed |
| WO-2023220435-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023220439-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023220433-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| CN-117051455-A | Tinning and photoresist removing process method for IC lead frame | 宁波德洲精密电子有限公司 | 2023-11-14 | — | — | CN | disclosed |
| WO-2023212237-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023212239-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023212231-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| CN-115337444-B | Preparation method of electronegative micromolecule-regulated procoagulant surface | 北京化工大学 | 2023-10-20 | — | — | CN | disclosed |
| US-20230331718-A1 | COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-10-19 | — | — | US | disclosed |
| EP-4259627-A1 | SULFOXIMINE PESTICIDES | BASF SE (DE) | 2023-10-18 | — | — | EP | disclosed |
| US-20230322724-A1 | HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS | AURIGENE ONCOLOGY LIMITED (IN) | 2023-10-12 | — | — | US | disclosed |
| CN-116724998-A | Efficient antioxidant donkey sperm diluent as well as preparation method and application thereof | 内蒙古自治区农牧业科学院 | 2023-09-12 | — | — | CN | disclosed |
| CN-116724998-A | Efficient antioxidant donkey sperm diluent as well as preparation method and application thereof | 内蒙古自治区农牧业科学院 | 2023-09-12 | — | — | CN | disclosed |
| CN-116724999-A | Diluent for promoting donkey sperm to supply energy and preparation method and application thereof | 内蒙古自治区农牧业科学院 | 2023-09-12 | — | — | CN | disclosed |
| CN-116724999-A | Diluent for promoting donkey sperm to supply energy and preparation method and application thereof | 内蒙古自治区农牧业科学院 | 2023-09-12 | — | — | CN | disclosed |
| CN-116495774-B | Silicon aerogel and preparation method thereof | 希纳高科(江苏)有限公司 | 2023-08-25 | — | — | CN | disclosed |
| WO-2023148368-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | SYNGENTA CROP PROTECTION AG (CH) | 2023-08-10 | — | — | WO | disclosed |
| CN-116495774-A | Silicon aerogel and preparation method thereof | 希纳高科(江苏)有限公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20230227474-A1 | COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-07-20 | — | — | US | disclosed |
| EP-4210683-A1 | HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS | Aurigene Oncology Limited (IN) | 2023-07-19 | — | — | EP | disclosed |
| CN-116408051-A | Sulfonic acid anion hybridization porous material, preparation method and ethylene-ethane separation method | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-116369304-A | Cell freezing solution without animal source component and preparation method thereof | 翌圣生物科技(上海)股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-20230183245-A1 | IMIDAZO-PYRIMIDONE COMPOUNDS AS PESTICIDES | BASF CHEMICALS INDIA PVT. LTD. (IN) | 2023-06-15 | — | — | US | disclosed |
| EP-4192454-A1 | COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2023-06-14 | — | — | EP | disclosed |
| WO-2023088718-A1 | BICYCLIC COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS | BASF SE (DE) | 2023-05-25 | — | — | WO | disclosed |
| US-20230141433-A1 | TRICYCLIC PESTICIDAL COMPOUNDS | BASF CHEMICALS INDIA PVT. LTD. (IN) | 2023-05-11 | — | — | US | disclosed |
| WO-2023081857-A1 | CONDENSED PYRIDAZINE AMINE DERIVATIVES TREATING SCA3 | SKYHAWK THERAPEUTICS, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023081860-A1 | TRIAZINE AMINO DERIVATIVES FOR TREATING SCA3 | SKYHAWK THERAPEUTICS, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023081859-A1 | TRIAZINE AMINO DERIVATIVES FOR TREATING SCA3 | SKYHAWK THERAPEUTICS, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023081858-A1 | CONDENSED-PYRAZINE AMINE DERIVATIVES FOR TREATING SCA3 | SKYHAWK THERAPEUTICS, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| US-11603531-B1 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| US-20230069804-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-03-02 | — | — | US | disclosed |
| US-20230067064-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-03-02 | — | — | US | disclosed |
| US-20230068499-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-03-02 | — | — | US | disclosed |
| US-20230059865-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-02-23 | — | — | US | disclosed |
| US-20230054781-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-02-23 | — | — | US | disclosed |
| WO-2023021375-A1 | FUNCTIONALIZED PHOSPHONATES, AND WATER-SOLUBLE SALTS AND N-OXIDE DERIVATIVES THEREOF, AND METHOD OF USE THEREOF AS SCALE INHIBITOR | DORF KETAL BRASIL LTDA, BRAZIL (BR) | 2023-02-23 | — | — | WO | disclosed |
| EP-4136086-A1 | TRICYCLIC PESTICIDAL COMPOUNDS | BASF SE (DE) | 2023-02-22 | — | — | EP | disclosed |
| EP-4132927-A1 | IMIDAZO-PYRIMIDONE COMPOUNDS AS PESTICIDES | BASF SE (DE) | 2023-02-15 | — | — | EP | disclosed |
| US-20230025130-A1 | METHODS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-01-26 | — | — | US | disclosed |
| US-20230027684-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-01-26 | — | — | US | disclosed |
| US-20230013778-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LIMITED (IN) | 2023-01-19 | — | — | US | disclosed |
| US-20230020922-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-01-19 | — | — | US | disclosed |
| US-20230009712-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-01-12 | — | — | US | disclosed |
| US-20230008867-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2023-01-12 | — | — | US | disclosed |
| US-20220403383-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2022-12-22 | — | — | US | disclosed |
| CN-113832496-B | Biological semiconductor nano material and preparation method and application thereof | 云南大学 | 2022-11-22 | — | — | CN | disclosed |
| WO-2022128524-A1 | SULFOXIMINE PESTICIDES | BASF SE (DE) | 2022-06-23 | — | — | WO | disclosed |
| US-11326165-B1 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2022-05-10 | — | — | US | disclosed |
| EP-3982969-A1 | METHODS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| WO-2022053967-A1 | HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS | AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) | 2022-03-17 | — | — | WO | disclosed |
| CN-110835849-B | High-performance environment-friendly scouring agent composition and preparation method thereof | 太仓宝霓实业有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20220048890-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2022-02-17 | — | — | US | disclosed |
| US-20220048902-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2022-02-17 | — | — | US | disclosed |
| EP-3938352-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2022-01-19 | — | — | EP | disclosed |
| EP-3937942-A1 | COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING | Skyhawk Therapeutics, Inc. (US) | 2022-01-19 | — | — | EP | disclosed |
| CN-113854473-A | Method for preparing low-arsenic oyster protein peptide by adsorption of targeting nano silica gel material | 无锡定象改性硅胶材料有限公司 | 2021-12-31 | — | — | CN | disclosed |
| EP-3920926-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3920920-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3920910-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3920919-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3920918-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3920915-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3921311-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3920928-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3920917-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3920916-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| US-11162101-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2021-11-02 | — | — | US | disclosed |
| WO-2021209265-A1 | TRICYCLIC PESTICIDAL COMPOUNDS | BASF SE (DE) | 2021-10-21 | — | — | WO | disclosed |
| US-20210322409-A1 | METALLOENZYME INHIBITOR COMPOUNDS | SELENITY THERAPEUTICS (BERMUDA), LTD. (BM) | 2021-10-21 | — | — | US | disclosed |
| US-11129829-B2 | Methods for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2021-09-28 | — | — | US | disclosed |
| CN-107835712-B | Automated solution dispenser | 莱伯曼兹有限公司 | 2021-09-10 | — | — | CN | disclosed |
| US-11091475-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2021-08-17 | — | — | US | disclosed |
| US-11040034-B2 | Metalloenzyme inhibitor compounds | PHASEBIO PHARMACEUTICALS, INC. (US) | 2021-06-22 | — | — | US | disclosed |
| US-20210171519-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2021-06-10 | — | — | US | disclosed |
| WO-2021105960-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LIMITED (IN) | 2021-06-03 | — | — | WO | disclosed |
| US-11021708-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2021-06-01 | — | — | US | disclosed |
| US-11008572-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| WO-2020257184-A1 | METHODS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-12-24 | — | — | WO | disclosed |
| US-20200390765-A1 | METHODS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2020-12-17 | — | — | US | disclosed |
| WO-2020190793-A1 | COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-09-24 | — | — | WO | disclosed |
| US-20200277289-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2020-09-03 | — | — | US | disclosed |
| WO-2020163382-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163647-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163409-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163375-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163401-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163323-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163405-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163544-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163248-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163406-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163541-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| US-20200247799-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2020-08-06 | — | — | US | disclosed |
| EP-3689863-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2020-08-05 | — | — | EP | disclosed |
| US-20200224199-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2020-07-16 | — | — | US | disclosed |
| US-20200205406-A1 | MICROBIOCIDAL PHENYLAMIDINE DERIVATIVES WITH IMPROVED PLANT SAFETY PROPERTIES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-07-02 | — | — | US | disclosed |
| EP-3661509-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2020-06-10 | — | — | EP | disclosed |
| CN-110835849-A | High-performance environment-friendly scouring agent composition and preparation method thereof | 上海雅运新材料有限公司 | 2020-02-25 | — | — | CN | disclosed |
| EP-3599852-A1 | MICROBIOCIDAL PHENYLAMIDINE DERIVATIVES WITH IMPROVED PLANT SAFETY PROPERTIES | Syngenta Participations AG (CH) | 2020-02-05 | — | — | EP | disclosed |
| EP-3562487-A2 | METALLOENZYME INHIBITOR COMPOUNDS | Selenity Therapeutics (Bermuda), Ltd. (BM) | 2019-11-06 | — | — | EP | disclosed |
| CN-110191911-A | Organic polymer functional group modification silica gel and its production technology and use | 湖北硒诺唯新功能化硅胶材料有限公司 | 2019-08-30 | — | — | CN | disclosed |
| WO-2019156134-A1 | CHIRAL TETRADENTATE LIGAND, METHOD FOR PRODUCING SAME AND TRANSITION METAL COMPLEX OF SAID CHIRAL TETRADENTATE LIGAND | 高砂香料工業株式会社 | 2019-08-15 | — | — | WO | disclosed |
| US-20190152974-A1 | SUBSTITUTED PTERIDINES USEFUL FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2019-05-23 | — | — | US | disclosed |
| WO-2019028440-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2019-02-07 | — | — | WO | disclosed |
| US-20190008861-A1 | METALLOENZYME INHIBITOR COMPOUNDS | CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) | 2019-01-10 | — | — | US | disclosed |
| US-10144736-B2 | Substituted pteridines useful for the treatment and prevention of viral infections | GILEAD SCIENCES, INC. (US) | 2018-12-04 | — | — | US | disclosed |
| WO-2018178057-A1 | MICROBIOCIDAL PHENYLAMIDINE DERIVATIVES WITH IMPROVED PLANT SAFETY PROPERTIES | SYNGENTA PARTICIPATIONS AG (CH) | 2018-10-04 | — | — | WO | disclosed |
| US-10085984-B2 | Metalloenzyme inhibitor compounds | VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) | 2018-10-02 | — | — | US | disclosed |
| CN-105861124-B | A kind of cold-rolling emulsion and preparation method thereof with iron powder self-dispersing energy | 北京科技大学 | 2018-09-25 | — | — | CN | disclosed |
| CN-105861124-B | A kind of cold-rolling emulsion and preparation method thereof with iron powder self-dispersing energy | 北京科技大学 | 2018-09-25 | — | — | CN | disclosed |
| US-20180185362-A1 | METALLOENZYME INHIBITOR COMPOUNDS | CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) | 2018-07-05 | — | — | US | disclosed |
| WO-2018125800-A2 | METALLOENZYME INHIBITOR COMPOUNDS | VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) | 2018-07-05 | — | — | WO | disclosed |
| CN-107532007-A | Leuco triphenylmethane colorants as bluing agents in laundry care compositions | 美利肯公司 | 2018-01-02 | — | — | CN | disclosed |
| WO-2017162661-A1 | 1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-09-28 | — | — | WO | disclosed |
| CN-105026334-B | Method for producing hydraulic powder | 花王株式会社 | 2017-06-06 | — | — | CN | disclosed |
| CN-106698626-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-106698620-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-106698619-A | Composition formula of water treatment flocculating agent | 威海英卡瑞环保科技有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-106698618-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-05-24 | — | — | CN | disclosed |
| EP-2373280-B1 | NOVEL USE | GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LTD (GB) | 2017-05-10 | — | — | EP | disclosed |
| CN-106379974-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-02-08 | — | — | CN | disclosed |
| CN-106379973-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-02-08 | — | — | CN | disclosed |
| CN-106379972-A | Water treatment flocculant composition formula | 威海英卡瑞环保科技有限公司 | 2017-02-08 | — | — | CN | disclosed |
| CN-105861124-A | Cold-rolled emulsified liquid with iron powder self-dispersing performance and preparation method thereof | 北京科技大学 | 2016-08-17 | — | — | CN | disclosed |
| US-9259379-B2 | Oral care compositions for combatting dental erosion | GLAXO GROUP LIMITED (GB) | 2016-02-16 | — | — | US | disclosed |
| US-20150148308-A1 | PEST CONTROL COMPOSITION FOR HARMFUL ARTHROPODS, AND PEST CONTROL METHOD FOR HARMFUL ARTHROPODS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-05-28 | — | — | US | disclosed |
| EP-2865266-A1 | PEST CONTROL COMPOSITION FOR HARMFUL ARTHROPODS, AND PEST CONTROL METHOD FOR HARMFUL ARTHROPODS | Sumitomo Chemical Company, Limited (JP) | 2015-04-29 | — | — | EP | disclosed |
| US-8921412-B2 | C-aryl ansa SGLT2 inhibitors | GREEN CROSS CORPORATION (KR) | 2014-12-30 | — | — | US | disclosed |
| CN-102459236-B | Pyrimidine inhibitors of kinase activity | ABBVIE (US) | 2014-10-29 | — | — | CN | disclosed |
| CN-104053646-A | Method for producing 3-mercaptopropionic acid, and carbonic acid ester composition having mercapto group using same, and method for producing thiourethane-based optical materials | KOC SOLUTION CO LTD | 2014-09-17 | — | — | CN | disclosed |
| US-20140213642-A1 | NOVEL C-ARYL ANSA SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2014-07-31 | — | — | US | disclosed |
| CN-102245157-B | Novel use of triple polymer system and a source of fluoride ions in oral care composition | GLAXO GROUP LTD | 2014-05-07 | — | — | CN | disclosed |
| US-20140037556-A1 | Novel Use | BLOCK DRUG COMPANY INC | 2014-02-06 | — | — | US | disclosed |
| CN-103261170-A | Fused heterocyclic compounds and their use for pest control | SUMITOMO CHEMICAL CO | 2013-08-21 | — | — | CN | disclosed |
| CN-103180296-A | Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer | AMGEN INC | 2013-06-26 | — | — | CN | disclosed |
| CN-103102389-A | Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease | SCHERING CORP | 2013-05-15 | — | — | CN | disclosed |
| US-8383305-B2 | Image forming apparatus | RICOH COMPANY, LTD. (JP) | 2013-02-26 | — | — | US | disclosed |
| EP-2540711-A1 | SELENALZOLE DERIVATIVE HAVING LIGAND WHICH ACTIVATES PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR), PREPARING METHOD THEREOF AND USAGE OF THE CHEMICAL COMPOUNDS | SNU R & DB Foundation (KR) | 2013-01-02 | — | — | EP | disclosed |
| WO-2012173410-A2 | NOVEL C-ARYL ANSA SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2012-12-20 | — | — | WO | disclosed |
| US-20120316346-A1 | SELENALZOLE DERIVATIVE HAVING LIGAND WHICH ACTIVATES PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR), PREPARING METHOD THEREOF AND USAGE OF THE CHEMICAL COMPOUNDS | SNU R & DB FOUNDATION (KR) | 2012-12-13 | — | — | US | disclosed |
| EP-2278407-B1 | Image forming apparatus | RICOH CO LTD (JP) | 2012-10-10 | — | — | EP | disclosed |
| US-8188085-B2 | Antifungal agents | MERCK SHARP & DOHME CORP. (US) | 2012-05-29 | — | — | US | disclosed |
| CN-102459236-A | Pyrimidine inhibitors of kinase activity | ABBOTT LAB | 2012-05-16 | — | — | CN | disclosed |
| CN-1960969-B | Histamine H3 receptor agents, methods of preparation and therapeutic uses thereof | LILLY CO ELI | 2012-03-28 | — | — | CN | disclosed |
| US-20110286777-A1 | LUBRICANT AND IMAGE FORMING APPARATUS AND PROCESS CARTRIDGE USING SAME | RICOH COMPANY, LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
| CN-102245157-A | Novel use | GLAXO GROUP LTD | 2011-11-16 | — | — | CN | disclosed |
| CN-1841216-B | Toner processes | XEROX CORP | 2011-11-16 | — | — | CN | disclosed |
| US-20110256074-A1 | NOVEL USE | GLAXO GROUP LIMITED (GB) | 2011-10-20 | — | — | US | disclosed |
| EP-2373280-A1 | NOVEL USE | Glaxo Group Limited (GB) | 2011-10-12 | — | — | EP | disclosed |
| CN-102131776-A | Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof | BAYER SCHERING PHARMA AG | 2011-07-20 | — | — | CN | disclosed |
| CN-102112463-A | 5-substituted isoindoline compounds | CELGENE CORP | 2011-06-29 | — | — | CN | disclosed |
| US-7964071-B2 | Device with π-conjugated metal complex immobilized substrate in aqueous electrolyte | CANON KABUSHIKI KAISHA (JP) | 2011-06-21 | — | — | US | disclosed |
| EP-2326181-A1 | ANTIFUNGAL AGENTS | Merck Sharp & Dohme Corp. (US) | 2011-06-01 | — | — | EP | disclosed |
| CN-102036972-A | Treatment of duchenne muscular dystrophy | SUMMIT CORP PLC | 2011-04-27 | — | — | CN | disclosed |
| US-20110020740-A1 | IMAGE FORMING APPARATUS | RICOH COMPANY, LTD (JP) | 2011-01-27 | — | — | US | disclosed |
| US-20110021473-A1 | INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | RANBAXY LABORATORIES LIMITED | 2011-01-27 | — | — | US | disclosed |
| EP-2278407-A1 | Image forming apparatus | Ricoh Company, Ltd. (JP) | 2011-01-26 | — | — | EP | disclosed |
| CN-101932579-A | Novel imidazo-heteroaryl derivatives with antibacterial properties | MUTABILIS SA | 2010-12-29 | — | — | CN | disclosed |
| US-20100305117-A1 | SUBSTITUTED PTERIDINES USEFUL FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. (US) | 2010-12-02 | — | — | US | disclosed |
| CN-101013277-B | Electrostatic latent image bearing member, and image forming apparatus, process cartridge, and image forming method using the same | RICOH KK | 2010-10-06 | — | — | CN | disclosed |
| WO-2010066655-A9 | NOVEL USE | GLAXO GROUP LIMITED (GB) | 2010-09-16 | — | — | WO | disclosed |
| US-7763702-B2 | Prepared by reacting a polyphosphonitrile with an amine or an alkali metal salt of an alcohol and an a perfluoroalkylsulfonylaminosulfonyl-substituted aniline or phenol salt; fuel cell membran materials | THE PENN STATE RESEARCH FOUNDATION (US) | 2010-07-27 | — | — | US | disclosed |
| WO-2010066655-A1 | NOVEL USE | GLAXO GROUP LIMITED (GB) | 2010-06-17 | — | — | WO | disclosed |
| US-20100113439-A1 | Antifungal agents | MERCK & CO., INC. (US) | 2010-05-06 | — | — | US | disclosed |
| WO-2010019204-A1 | ANTIFUNGAL AGENTS | MERCK SHARP & DOHME CORP. (US) | 2010-02-18 | — | — | WO | disclosed |
| US-7655671-B2 | Morphinan derivatives, the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof | ALCASYNN PHARMACEUTICALS GMBH (AT) | 2010-02-02 | — | — | US | disclosed |
| CN-100577658-C | Quinazoline derivatives | ASTRAZENECA AB | 2010-01-06 | — | — | CN | disclosed |
| US-7629094-B2 | Electrophotographic photoreceptor, and image forming method, image forming apparatus and process cartridge therefor using the electrophotographic photoreceptor | RICOH COMPANY, LTD. (JP) | 2009-12-08 | — | — | US | disclosed |
| CN-101578277-A | 5-substituted isoindoline compounds | CELGENE CORP (US) | 2009-11-11 | — | — | CN | disclosed |
| CN-100559289-C | Electrostatic latent image supporting body and with its image processing system, image forming method and handle box | RICOH KK (JP) | 2009-11-11 | — | — | CN | disclosed |
| EP-2086948-A2 | INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | Ranbaxy Laboratories Limited (IN) | 2009-08-12 | — | — | EP | disclosed |
| US-7544699-B2 | Aryl and heteroaryl compounds, compositions, and methods of use | TRANSTECH PHARMA, INC. (US) | 2009-06-09 | — | — | US | disclosed |
| US-20090054493-A1 | THIAZOLE DERIVATIVES AS PPAR DELTA LIGANDS AND THEIR MANUFACTURING PROCESS | Kang, Heonjoong Kang (KR) | 2009-02-26 | — | — | US | disclosed |
| US-20090048247-A1 | CONDENSED ISOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE TYPE - IV | RANBAXY LABORATORIES LIMITED (IN) | 2009-02-19 | — | — | US | disclosed |
| CN-101370806-A | Substituted 4-phenylpiperidines | SPEEDEL EXPERIMENTA AG (CH) | 2009-02-18 | — | — | CN | disclosed |
| US-20090026071-A1 | DEVICE WITH pi-CONJUGATED METAL COMPLEX IMMOBILIZED SUBSTRATE IN AQUEOUS ELECTROLYTE | CANON KABUSHIKI KAISHA (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1674940-B1 | Electrophotographic photoreceptor, and image forming method, image forming apparatus and process cartridge therefor using the electrophotographic photoreceptor | RICOH KK (JP) | 2008-11-26 | — | — | EP | disclosed |
| WO-2008035315-A9 | INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | RANBAXY LAB LTD (IN) | 2008-10-23 | — | — | WO | disclosed |
| WO-2008063625-A2 | PYRIDINE COMPOUNDS AND METHODS OF THEIR USE | ADOLOR CORPORATION (US) | 2008-05-29 | — | — | WO | disclosed |
| WO-2008035315-A2 | INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | RANBAXY LABORATORIES LIMITED (IN) | 2008-03-27 | — | — | WO | disclosed |
| US-20080064712-A1 | Morphinan derivatives, the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof | ALCASYNN PHARMACEUTICALS GMBH | 2008-03-13 | — | — | US | disclosed |
| WO-2008009079-A2 | SUBSTITUTED PTERIDINES USEFUL FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| US-20080009535-A1 | Inhibitors of phosphodiesterase type-IV | RANBAXY LABORATORIES LIMITED (IN) | 2008-01-10 | — | — | US | disclosed |
| EP-1869054-A2 | CONDENSED ISOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | Ranbaxy Laboratories Limited (IN) | 2007-12-26 | — | — | EP | disclosed |
| EP-1856072-A1 | THIAZOLE DERIVATIVES AS PPAR DELTA LIGANDS AND THEIR MANUFACTURING PROCESS | Kang, Heonjoong (KR) | 2007-11-21 | — | — | EP | disclosed |
| CN-101076516-A | Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease | SCHERING CORP (US) | 2007-11-21 | — | — | CN | disclosed |
| US-20070265426-A1 | Prepared by reacting a polyphosphonitrile with an amine or an alkali metal salt of an alcohol and an a perfluoroalkylsulfonylaminosulfonyl-substituted aniline or phenol salt; fuel cell membran materials | THE PENN STATE RESEARCH FOUNDATION (US) | 2007-11-15 | — | — | US | disclosed |
| CN-101063834-A | Electrostatic latent image bearing member, and image forming apparatus and process cartridge using the electrostatic latent image bearing member | RICOH KK (JP) | 2007-10-31 | — | — | CN | disclosed |
| EP-1840123-A1 | Isoxazolines and their use as inhibitors of phosphodiesterase type-IV | Ranbaxy Laboratories Limited (IN) | 2007-10-03 | — | — | EP | disclosed |
| CN-101013277-A | Electrostatic latent image bearing member, and image forming apparatus, process cartridge, and image forming method using the same | RICOH KK (JP) | 2007-08-08 | — | — | CN | disclosed |
| CN-1960969-A | Histamine H3 receptor agents, methods of preparation and therapeutic uses thereof | LILLY CO ELI (US) | 2007-05-09 | — | — | CN | disclosed |
| EP-1120423-B1 | Improved chemiluminescent 1,2-dioxetanes | APPLERA CORP (US) | 2007-03-14 | — | — | EP | disclosed |
| CN-1886399-A | Quinazoline derivatives | ASTRAZENECA AB (SE) | 2006-12-27 | — | — | CN | disclosed |
| US-20060281726-A1 | Piperidine derivatives for the treatment of chemokine or h1 mediated disease state | ASTRAZENECA AB (SE) | 2006-12-14 | — | — | US | disclosed |
| CN-1841216-A | Toner processes | XEROX CORP (US) | 2006-10-04 | — | — | CN | disclosed |
| CN-1832920-A | Aryl and heteroaryl compounds, compositions, and methods of use | TRANSTECH PHARMA INC (US) | 2006-09-13 | — | — | CN | disclosed |
| WO-2006091047-A1 | THIAZOLE DERIVATIVES AS PPAR DELTA LIGANDS AND THEIR MANUFACTURING PROCESS | KANG HEONJOONG (KR) | 2006-08-31 | — | — | WO | disclosed |
| WO-2006085212-A2 | CONDENSED ISOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | RANBAXY LABORATORIES LIMITED (IN) | 2006-08-17 | — | — | WO | disclosed |
| US-20060160003-A1 | Electrophotographic photoreceptor, and image forming method, image forming apparatus and process cartridge therefor using the electrophotographic photoreceptor | RICOH COMPANY, LTD. (JP) | 2006-07-20 | — | — | US | disclosed |
| EP-1674940-A1 | Electrophotographic photoreceptor, and image forming method, image forming apparatus and process cartridge therefor using the electrophotographic photoreceptor | Ricoh Company, Ltd. (JP) | 2006-06-28 | — | — | EP | disclosed |
| EP-1660439-A2 | ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | Transtech Pharma, Inc. (US) | 2006-05-31 | — | — | EP | disclosed |
| WO-2006043121-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | RANBAXY LABORATORIES LIMITED (IN) | 2006-04-27 | — | — | WO | disclosed |
| CN-1764651-A | Quinazoline derivatives as antitumor agents | ASTRAZENECA AB (SE) | 2006-04-26 | — | — | CN | disclosed |
| EP-1611124-A1 | PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CHEMOKINE OR H1 MEDIATED DISEASE STATE | AstraZeneca AB (SE) | 2006-01-04 | — | — | EP | disclosed |
| WO-2005100301-A1 | 2-ARYLOXYETHYL GLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS | ELI LILLY AND COMPANY (US) | 2005-10-27 | — | — | WO | disclosed |
| US-20050182258-A1 | Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof | ALCASYNN PHARMACEUTICALS GMBH (AT) | 2005-08-18 | — | — | US | disclosed |
| US-20050059705-A1 | Aryl and heteroaryl compounds, compositions, and methods of use | VTVX HOLDINGS I LLC | 2005-03-17 | — | — | US | disclosed |
| WO-2005014533-A2 | ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | TRANSTECH PHARMA, INC. (US) | 2005-02-17 | — | — | WO | disclosed |
| US-20040225153-A1 | Synthesis of polyphosphazenes with sulfonimide side groups | THE PENN STATE RESEARCH FOUNDATION | 2004-11-11 | — | — | US | disclosed |
| WO-2004085423-A1 | PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CHEMOKINE OR H1 MEDIATED DISEASE STATE | ASTRAZENECA AB (SE) | 2004-10-07 | — | — | WO | disclosed |
| WO-2004072141-A2 | SYNTHESIS OF POLYPHOSPHAZENES WITH SULFONIMIDE SIDE GROUPS | THE PENN STATE RESEARCH FOUNDATION (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-0950657-B1 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors | LILLY CO ELI (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-0952149-B1 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors | LILLY CO ELI (US) | 2004-06-09 | — | — | EP | disclosed |
| US-6713645-B1 | INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK | ELI LILLY AND COMPANY | 2004-03-30 | — | — | US | disclosed |
| CN-1136186-C | Method for preparing intermediate of methylsalfonamido phenethylamine derivative | 中国药科大学 | 2004-01-28 | — | — | CN | disclosed |
| EP-0874809-B1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2003-08-27 | — | — | EP | disclosed |
| EP-1140943-B1 | SUBSTITUTED PYRROLOINDOLES | LILLY CO ELI (US) | 2003-08-13 | — | — | EP | disclosed |
| US-6448284-B1 | PYRROLO(1,2-A)INDOLES; INHIBITING NONPANCREATIC SECRETORY PHOSPHOLIPASE A2 MEDIATED RELEASE OF FATTY ACIDS; SEPTIC SHOCK | ELI LILLY AND COMPANY | 2002-09-10 | — | — | US | disclosed |
| US-6346615-B1 | SPIROADAMANTYL DIOXETANES BEARING AN ALKOXY SUBSTITUENT, AND AN AROMATIC SUBSTITUENT ON THE DIOXETANE RING CAN BE ACTIVATED TO CHEMILUMINESCE IF THE AROMATIC SUBSTITUENT BEARS A MOIETY THAT IS CLEAVED BY AN ENZYME | TROPIX, INC. | 2002-02-12 | — | — | US | disclosed |
| EP-1140943-A2 | SUBSTITUTED PYRROLOINDOLES | ELI LILLY AND COMPANY (US) | 2001-10-10 | — | — | EP | disclosed |
| US-6239175-B1 | Carbamoyloxy derivatives of mutiline and their use as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-05-29 | — | — | US | disclosed |
| CN-1287999-A | Method for preparing intermediate of methylsalfonamido phenethylamine derivative | CHINA PHARMACEUTICAL SCIENCE U (CN) | 2001-03-21 | — | — | CN | disclosed |
| US-6177440-B1 | THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR | ELI LILLY AND COMPANY | 2001-01-23 | — | — | US | disclosed |
| US-6140495-A | SPIROADAMANTYL DIOXETANES BEARING AN ALKOXY SUBSTITUENT AND AN AROMATIC SUBSTITUENT OF PHENYL OR NAPHTHYL ON THE DIOXETANE RING; REPORTER MOLECULES FOR MEASUREMENT OF ENZYMATIC ACTIVITY | TROPIX, INC. (US) | 2000-10-31 | — | — | US | disclosed |
| CN-1055682-C | Novel method for preparing methanesulfonamido phenethylamine derivative | UNIV CHINA PHARMACY (CN) | 2000-08-23 | — | — | CN | disclosed |
| WO-2000037472-A2 | SUBSTITUTED PIRROLOINDOLES | ELI LILLY AND COMPANY (US) | 2000-06-29 | — | — | WO | disclosed |
| US-6022964-A | SPIROADAMANTYL DIOXETANES WITH AN ALKOXY SUBSTITUENT AND A NAPHTHYL SUBSTITUENT ON THE DIOXETANE RING WHICH CAN BE ACTIVATED BY ENZYMATIC CLEAVAGE OF LABILE GROUP; KINETICS AND SIGNAL INTENSITY DEPENDS ON ELECTRON-ACTIVATING GROUP | TROPIX, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| US-6020368-A | MICROBIOCIDES | HINKS JEREMY DAVID (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0952149-A2 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors | ELI LILLY AND COMPANY (US) | 1999-10-27 | — | — | EP | disclosed |
| EP-0950657-A2 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors | ELI LILLY AND COMPANY (US) | 1999-10-20 | — | — | EP | disclosed |
| US-5851771-A | Chemiluminescent 1,2-dioxetanes | TROPIX, INC. (US) | 1998-12-22 | — | — | US | disclosed |
| US-5840919-A | SPIROADAMANTYL 1,2-DIOXETANES CHARACTERIZED BY SUBSTITUENT ON AROMATIC RING IN ADDITION TO META-SUBSTITUTED ENZYME-LABILE GROUP | TROPIX, INC. (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0874809-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1998-11-04 | — | — | EP | disclosed |
| US-5763681-A | ALPHA-2-ADAMANTYLIDENE-ALPHA-METHOXY-META-METHOXYTOLUENE AND RELATED COMPOUNDS AS INTERMEDIATES | TROPIX, INC. (US) | 1998-06-09 | — | — | US | disclosed |
| CN-1156142-A | Novel method for preparing methanesulfonamido phenethylamine derivative | UNIV CHINA PHARMACY (CN) | 1997-08-06 | — | — | CN | disclosed |
| WO-1997025309-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1997-07-17 | — | — | WO | disclosed |
| US-5538847-A | Chemiluminescent 1,2-dioxetanes | TROPIX, INC. (US) | 1996-07-23 | — | — | US | disclosed |
| EP-0543584-B1 | Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system | LILLY INDUSTRIES LTD (GB) | 1996-05-22 | — | — | EP | disclosed |
| US-5519027-A | PROGESTERONE ANTAGONIST FOR OXYTOCICS OR PREVENTION OF TERMINATION OF PREGNANCY | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-05-21 | — | — | US | disclosed |
| EP-0446793-B1 | Preparation process of polymeric solid electrolyte | NIPPON OIL CO LTD (JP) | 1995-08-02 | — | — | EP | disclosed |
| EP-0649417-A1 | IMPROVED CHEMILUMINESCENT 1,2-DIOXETANES | TROPIX, INC. (US) | 1995-04-26 | — | — | EP | disclosed |
| EP-0649417-A4 | IMPROVED CHEMILUMINESCENT 1,2-DIOXETANES. | TROPIX INC (US) | 1995-02-27 | — | — | EP | disclosed |
| WO-1994026726-A1 | IMPROVED CHEMILUMINESCENT 1,2-DIOXETANES | TROPIX, INC. (US) | 1994-11-24 | — | — | WO | disclosed |
| US-5338735-A | For treatment of central nervous system disorders | LILLY INDUSTRIES LIMITED (GB) | 1994-08-16 | — | — | US | disclosed |
| US-5233000-A | Pulverant nonconductors | THE LUBRIZOL CORPORATION (US) | 1993-08-03 | — | — | US | disclosed |
| US-5225584-A | Phosphonate esters and trialkylsilyl phosphonate esters | TROPIX, INC. (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0543584-A1 | Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system | LILLY INDUSTRIES LIMITED (GB) | 1993-05-26 | — | — | EP | disclosed |
| US-5194490-A | Polyelectrolytes for lithium cells | NIPPON OIL CO., LTD. (JP) | 1993-03-16 | — | — | US | disclosed |
| EP-0441948-A4 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | — | 1992-06-03 | — | — | EP | disclosed |
| EP-0446793-A1 | Preparation process of polymeric solid electrolyte | Nippon Oil Co., Ltd. (JP) | 1991-09-18 | — | — | EP | disclosed |
| EP-0441948-A1 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | TROPIX, INC. (US) | 1991-08-21 | — | — | EP | disclosed |
| US-5023133-A | Partially protonated polyaniline; for determining acidity of motor vehicle lubrication oil | THE LUBRIZOL CORPORATION (US) | 1991-06-11 | — | — | US | disclosed |
| WO-1991003479-A1 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | TROPIX, INC. (US) | 1991-03-21 | — | — | WO | disclosed |
| US-4960761-A | High surface area polymers of pyrrole or copolymers of pyrrole | THE LUBRIZOL CORPORATION (US) | 1990-10-02 | — | — | US | disclosed |
| EP-0379174-A2 | 2,3-Dihydro-3,3-dimethyl-5-trifluoromethanesulfonyloxybenzofurans, process for producing them and herbicides containing them | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-07-25 | — | — | EP | disclosed |
| US-4921861-A | 3-AMINO-4-/ETHYLTHIO/QUINOLINE, AS ANXIOLYTIC AGENT AND NARCOSIS POTENTIATOR | BASF AKTIENGESELLSCHAFT (DE) | 1990-05-01 | — | — | US | disclosed |
| US-4839322-A | ELECTROCONDUCTIVE SURFACE; CATALYST | THE LUBRIZOL CORPORATION (US) | 1989-06-13 | — | — | US | disclosed |
| US-4810628-A | ANIONIC POLYURETHANE BINDER | AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1989-03-07 | — | — | US | disclosed |
| US-4791374-A | IN LUBRICATING OIL OF INTERNAL COMBUSTION AND DIESEL ENGINES USING AN ELECTROCONDUCTIVE POLYMER | THE LUBRIZOL CORPORATION (US) | 1988-12-13 | — | — | US | disclosed |
| US-4533670-A | ANTIEPILEPTIC AGENTS | ELI LILLY AND COMPANY (US) | 1985-08-06 | — | — | US | disclosed |
| EP-0028143-B1 | FABRIC WASHING PROCESS AND DETERGENT COMPOSITION FOR USE THEREIN | UNILEVER PLC (GB) | 1983-09-21 | — | — | EP | disclosed |
| EP-0009953-B1 | DETERGENT COMPOSITIONS | UNILEVER PLC (GB) | 1983-04-13 | — | — | EP | disclosed |
| EP-0009953-B1 | DETERGENT COMPOSITIONS | UNILEVER PLC (GB) | 1983-04-13 | — | — | EP | disclosed |